You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MALT

Showing 1 - 25 of 183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

Not yet recruiting
  • Primary Ocular Adnexal MALT Lymphoma
  • (no location specified)
Sep 26, 2023

Constipation, Quality of Life, Methane Production Trial in Manchester (Enzyme-rich malt extract)

Completed
  • Constipation
  • +2 more
  • Enzyme-rich malt extract
  • Manchester, Greater Manchester, United Kingdom
    The Functional Gut Clinic
Sep 22, 2022

Acute Response to Food Ingredient Consumption Trial in Lausanne (Malt ingredient, Non-alcoholic beer solids)

Completed
  • Acute Response to Food Ingredient Consumption
  • Malt ingredient
  • Non-alcoholic beer solids
  • Lausanne, Switzerland
    Société des produits Nestlé/Metabolic Unit
Feb 7, 2022

Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal

Completed
Has Results
  • Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Copenhagen, Denmark
  • +9 more
Jan 27, 2023

Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Houston (Radiation Therapy)

Recruiting
  • Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2021

MALT Lymphoma Trial in France, Italy, Switzerland (Chlorambucil, Rituximab i.v., Rituximab s.c.)

Active, not recruiting
  • MALT Lymphoma
  • Créteil, France
  • +37 more
Nov 4, 2022

Lymphoma Trial in Seoul (rituximab, cyclophosphamide, vincristine, and prednisolone)

Completed
  • Lymphoma
  • rituximab, cyclophosphamide, vincristine, and prednisolone
  • Seoul, Korea, Republic of
  • +1 more
May 3, 2021

Antibiotics-unresponsive MALT Lymphoma, Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma, Refractory Extranodal

Not yet recruiting
  • Antibiotics-unresponsive MALT Lymphoma
  • +2 more
  • Lenalidomide [Leavdo®]
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 25, 2020

DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Louisville, Kentucky
  • +6 more
Nov 14, 2022

Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia Trial in Australia,

Recruiting
  • Follicular Lymphoma
  • +7 more
  • Louisville, Kentucky
  • +4 more
Mar 11, 2022

Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

Not yet recruiting
  • Mature B-Cell Neoplasm
  • +25 more
  • (no location specified)
Sep 14, 2022

Growth and Development Trial in Pune (Fortified malt based food)

Completed
Has Results
  • Growth and Development
  • Fortified malt based food
  • Pune, India
    GSK Investigational Site
Nov 15, 2019

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Stony Brook, New York
  • +27 more
Aug 11, 2022

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • (no location specified)
Aug 23, 2022

Language Development Disorders Trial (VAULT Phase 5)

Not yet recruiting
  • Language Development Disorders
  • VAULT Phase 5
  • (no location specified)
Jun 26, 2023

Language Development Disorders Trial in Tucson (VAULT Phase 4)

Recruiting
  • Language Development Disorders
  • VAULT Phase 4
  • Tucson, Arizona
    University of Arizona
Jun 26, 2023

Language Development Disorders Trial (VAULT Phase 6)

Not yet recruiting
  • Language Development Disorders
  • VAULT Phase 6
  • (no location specified)
Jun 26, 2023

Lymphoma Trial in Milan (clarithromycin, oral, high dose)

Completed
  • Lymphoma
  • clarithromycin, oral, high dose
  • Milan, Italy
    Dpt of OncoHematology - Fondazione Centro San Raffaele del Monte
Aug 10, 2022

Helicobacter Pylori Infection Trial in Karachi (Vonoprazan, Amoxicillin, Levofloxacin)

Recruiting
  • Helicobacter Pylori Infection
  • Vonoprazan, Amoxicillin, Levofloxacin
  • Karachi, Sindh, Pakistan
    Aga Khan University Hospital
Feb 5, 2023

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Milano (intralesional rituximab, supplemental autologous

Completed
  • Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
  • intralesional rituximab
  • supplemental autologous serum
  • Milano, Italy
    Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 2, 2022

Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)

Recruiting
  • Indolent Lymphoma
  • Low-dose Radiotherapy
  • Low-dose radiotherapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 13, 2022

Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
Nov 4, 2022

Bronchoscopic Microwave Ablation of Lung Tissue

Not yet recruiting
  • Lung Cancer
  • Ablation
  • London, United Kingdom
    Royal Brompton and Harefield NHS Foundation Trust
Mar 24, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Santa Monica, California
  • +4 more
Sep 15, 2021